From bench to crib: translating human milk bioactive peptides into infant health interventions

Yasuri Amarasekara1,2, Anwar Sunna1,2, J Bruce German3,4

  • 1School of Natural Sciences, Macquarie University, Sydney, Australia.

Insights

Human milk peptides are key for infant development beyond nutrition. This review proposes evaluating their function within infant physiology for better nutrition strategies.

Area of Science:

  • Developmental Biology
  • Nutritional Science
  • Peptidomics

Background:

  • Human milk (HM)-derived peptides significantly influence infant development, impacting immunity, gut health, and neurodevelopment.
  • Current research often focuses narrowly on molecular aspects, neglecting the peptides' role in overall infant health outcomes.
  • Existing discovery methods rely heavily on in vitro studies, adult models, and high doses, limiting translational relevance.

Purpose of the Study:

  • To reframe bioactive milk peptides as evolutionarily adapted molecules evaluated within infant physiology.
  • To identify limitations in current peptide discovery pipelines and propose a translational framework.
  • To outline a roadmap for identifying clinically relevant peptides for next-generation infant nutrition.

Main Methods:

  • Reviewing current literature on human milk peptides and infant development.
  • Analyzing limitations of existing in vitro assays, adult models, and dosing strategies.
  • Proposing integration of peptidomics, infant-specific models, and systems-level validation.

Main Results:

  • Current methods for studying milk peptides are insufficient for understanding their developmental impact.
  • A translational framework integrating developmental biology is needed.
  • A roadmap combining advanced techniques can prioritize peptides for clinical relevance.

Conclusions:

  • Shifting focus from molecular activity to developmental impact is crucial.
  • This approach will enable precision therapeutics and next-generation nutrition strategies.
  • Understanding peptide function in infant physiology is key to harnessing their full potential.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
38
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
38
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
65
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762